1. GSK takes RSV maternal vaccine candidate into phase 3 testing — FDA approves Alnylam's first-ever drug for rare kidney disease — FDA approves Roche's Xofluza to prevent flu spreading within families — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

HHS Secretary Azar discussed firing FDA chief Hahn after showdown over COVID-19 vaccine...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 23, 2020 at 11:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Nov 21, 2001
    Likes Received:
    via President Donald Trump touted a COVID-19 vaccine ready for Election Day, and behind the scenes, his officials tried to make it happen. But despite intense pressure, the FDA publicly rolled out stricter safety guidelines that thwarted those hopes—and now Commissioner Stephen Hahn, M.D., is reportedly at odds with his boss, HHS chief Alex Azar.

    article source